NEW YORK (GenomeWeb) – Tebu-bio today announced an agreement to offer Toray's 3D-Gene miRNA and mRNA profiling technology to European researchers.

Tokyo-based Toray has been offering the platform in Japan for years, and the deal announced today is part of its plans to expand into Europe by entering into strategic collaborations. France-based Tebu-bio is now certified by Toray to provide the 3D-Gene Platform Expression Profiling Technology as a service in Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.